Impact of medication nonadherence on coronary heart disease outcomes: A critical review

Archives of Internal Medicine

Volumn 157, Issue 17, 1997, Pages 1921-1929

  McDermott, Mary McGrae ^a,c,d   Schmitt, Brian ^b   Wallner, Elisabeth ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Robert Wood Johnson Generalist P   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; COLESTYRAMINE; FISH OIL; NIFEDIPINE; PROPRANOLOL;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MORTALITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESTENOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0030931870     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.17.1921     Document Type: Review

References (34)

1. Goodman L. Medical Knowledge Self Assessment Program X: Cardiovascular Medicine. Philadelphia, Pa: American College of Physicians; 1994:417.
2. Udvarhelyi IS, Gatsonis C, Epstein AM, et al. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA. 1992;268:2530-2536.
3. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
4. Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines, Committee on Evaluation and Management of Heart Failure. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376-1398.
5. Shepard J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333: 1301-1307.
6. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the Ongoing Physician's Health Study. N Engl J Med. 1989;321:129-135.
7. Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of anti-platelet therapy, I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308: 81-106.
8. Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarctions: from randomized trials to clinical practice. J Am Coll Cardiol. 1995;25:1327-1332.
9. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J. 1985;6:199-226.
10. Pfeffer MA, Braunwald C, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
11. Obias-Manno D, Friedmann E, Mor Brooks M, et al. Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Ann Epidemiol. 1996;6:93-101.
12. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1986;8:1271-1276.
13. Reis GJ, Sipperly ME, McCabe CH, et al. Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989;2:177-181.
14. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1707-1714.
15. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA. 1993; 270:742-744.
16. Stegman MR, Miller PJ, Hageman RK, et al. Myocardial infarction survival: how important are patients' attitudes and adherence behaviors? Am J Prev Med. 1987;3:147-151.
17. The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 1980;303:1038-1041.
18. Rich MW, Beckham V, Wittenberg C. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
19. Rich MW, Vinson JM, Sperry JC, et al. Prevention of readmission in elderly patients with congestive heart failure. J Gen Intern Med. 1993;8:585-590.
20. Rosenberg SG. Patient education leads to better care for heart patients. HSMHA Health Rep. 1981; 86:793-802.
21. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
22. Romm FJ, Hulka BS, Mayo F. Correlates of outcomes in patients with congestive heart failure. Med Care. 1976;14:765-776.
23. Ghali JK, Kadakis S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Arch Intern Med. 1988;148:2013-2016.
24. Pentimone F, Del Corso L. Scompenso Congestizio e ricoveri ripetuti nell'anziano. Clin Ter. 1993; 142:207-210.
25. Wagdi P, Vuilliomenet A, Kaufmann U, Richter M, Bertel O. Ungenuegende Behandlungsdisziplin, Patienteninformation und Medikamentenverschreibung als Ursachen fuer die Notfallhospitalisation bei chronisch herzinsuffizienten Patienten. Schweiz Med Wochenschr. 1993;123:108-112.
26. Goldberger JJ, Peled HB, Stroh JA, et al. Prognostic factors in acute pulmonary edema. Arch Intern Med. 1986;146:489-493.
27. Psaty BM, Koepsell TD, Wagner EH. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 1990;263:1653-1657.
28. Maronde RF, Chan LS, Larsen FJ, et al. Underutilization of antihypertensive drugs and associated hospitalization. Med Care. 1989;27:1159-1166.
29. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
30. Sampson JJ, Arbona CL. Causes and effects of noncompliance in cardiac patients. Clin Cardiol. 1980;3:207-210.
31. Davidsen F, Haghfelt T, Gram LF, Brosen K. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol. 1988;34:83-86.
32. McDermott MM, Feinglass J, Lefevre F, et al. Outcomes for 1617 patients hospitalized with congestive heart failure between 1986 and 1994: trends in patient characteristics, drug prescribing practices, hospital readmissions, and survival. J Gen Intern Med. 1996;11:80. Abstract.
33. Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298-305.
34. Miller P, Johnson N, Garrett MJ, et al. Health beliefs of and adherence to the medical regimen by patients with ischemic heart disease. Heart Lung. 1982;11:332-339.